高血压在缺血性中风首次发作患者中的意义:20年回顾性研究

IF 1.2 Q3 CARDIAC & CARDIOVASCULAR SYSTEMS
P. Luque-Linero , M.C. Fernández-Moreno , J.A. Pérez de León-Serrano , L. Castilla-Guerra
{"title":"高血压在缺血性中风首次发作患者中的意义:20年回顾性研究","authors":"P. Luque-Linero ,&nbsp;M.C. Fernández-Moreno ,&nbsp;J.A. Pérez de León-Serrano ,&nbsp;L. Castilla-Guerra","doi":"10.1016/j.hipert.2023.04.002","DOIUrl":null,"url":null,"abstract":"<div><h3>Background and objectives</h3><p>Hypertension (HT) is a key risk factor for stroke. We evaluated whether the importance of hypertension on the risk of ischemic stroke has increased in recent decades.</p></div><div><h3>Methods</h3><p>Retrospective study of patients with ischemic stroke discharged from 3 hospitals in Seville (Spain), during the periods: 1999-2001, 2014-2016 and 2019-2020.</p></div><div><h3>Results</h3><p>1,379 patients were included, 42.6% women, mean age 69.1 (±<!--> <!-->11) years. HT was the most prevalent vascular risk factor in all periods, with a progressive increase in hypertensive patients (65.9% vs 69.6% vs 74%; <em>P</em> <!-->=<!--> <!-->.029). HT was especially frequent in patients<!--> <!-->≥<!--> <!-->80 years (73% vs 81.9% vs 85.2%; <em>P</em> <!-->=<!--> <!-->.029). At discharge, progressively more antihypertensive drugs were used (in 65% vs 85.1 vs 90.2% of patients; <em>P</em> <!-->=<!--> <!-->.0001), with a clear increase in the number of antihypertensive drugs used (mean 0.9<!--> <!-->±<!--> <!-->0.8 vs 1.5<!--> <!-->±<!--> <!-->1 vs 1.8<!--> <!-->±<!--> <!-->0.8 drugs, <em>P</em> <!-->=<!--> <!-->.0001). The use of diuretics (13.7%-39.3%-65.3%; p<!--> <!-->=<!--> <!-->0.0001), ACE inhibitors (35.5%-43.3%-53.4%; <em>P</em> <!-->=<!--> <!-->.0001) and angiotensin receptor blockers (12.2%-24%-32.4%; <em>P</em> <!-->=<!--> <!-->.0001) increased progressively. On the contrary, the use of calcium antagonists decreased (24%-19.9%-13.7%; <em>P</em> <!-->=<!--> <!-->.0001).</p></div><div><h3>Conclusions</h3><p>In the last 2 decades there has been a greater role for HT among patients with their first ischemic cerebrovascular event. Greater and better control of HT is necessary to reduce the enormous burden of cerebrovascular disease.</p></div>","PeriodicalId":39403,"journal":{"name":"Hipertension y Riesgo Vascular","volume":null,"pages":null},"PeriodicalIF":1.2000,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Importancia de la hipertensión en pacientes con primer episodio de ictus isquémico: estudio retrospectivo de 20 años\",\"authors\":\"P. Luque-Linero ,&nbsp;M.C. Fernández-Moreno ,&nbsp;J.A. Pérez de León-Serrano ,&nbsp;L. Castilla-Guerra\",\"doi\":\"10.1016/j.hipert.2023.04.002\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Background and objectives</h3><p>Hypertension (HT) is a key risk factor for stroke. We evaluated whether the importance of hypertension on the risk of ischemic stroke has increased in recent decades.</p></div><div><h3>Methods</h3><p>Retrospective study of patients with ischemic stroke discharged from 3 hospitals in Seville (Spain), during the periods: 1999-2001, 2014-2016 and 2019-2020.</p></div><div><h3>Results</h3><p>1,379 patients were included, 42.6% women, mean age 69.1 (±<!--> <!-->11) years. HT was the most prevalent vascular risk factor in all periods, with a progressive increase in hypertensive patients (65.9% vs 69.6% vs 74%; <em>P</em> <!-->=<!--> <!-->.029). HT was especially frequent in patients<!--> <!-->≥<!--> <!-->80 years (73% vs 81.9% vs 85.2%; <em>P</em> <!-->=<!--> <!-->.029). At discharge, progressively more antihypertensive drugs were used (in 65% vs 85.1 vs 90.2% of patients; <em>P</em> <!-->=<!--> <!-->.0001), with a clear increase in the number of antihypertensive drugs used (mean 0.9<!--> <!-->±<!--> <!-->0.8 vs 1.5<!--> <!-->±<!--> <!-->1 vs 1.8<!--> <!-->±<!--> <!-->0.8 drugs, <em>P</em> <!-->=<!--> <!-->.0001). The use of diuretics (13.7%-39.3%-65.3%; p<!--> <!-->=<!--> <!-->0.0001), ACE inhibitors (35.5%-43.3%-53.4%; <em>P</em> <!-->=<!--> <!-->.0001) and angiotensin receptor blockers (12.2%-24%-32.4%; <em>P</em> <!-->=<!--> <!-->.0001) increased progressively. On the contrary, the use of calcium antagonists decreased (24%-19.9%-13.7%; <em>P</em> <!-->=<!--> <!-->.0001).</p></div><div><h3>Conclusions</h3><p>In the last 2 decades there has been a greater role for HT among patients with their first ischemic cerebrovascular event. Greater and better control of HT is necessary to reduce the enormous burden of cerebrovascular disease.</p></div>\",\"PeriodicalId\":39403,\"journal\":{\"name\":\"Hipertension y Riesgo Vascular\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":1.2000,\"publicationDate\":\"2023-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Hipertension y Riesgo Vascular\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S1889183723000247\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"CARDIAC & CARDIOVASCULAR SYSTEMS\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Hipertension y Riesgo Vascular","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1889183723000247","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CARDIAC & CARDIOVASCULAR SYSTEMS","Score":null,"Total":0}
引用次数: 0

摘要

背景与目的高血压(HT)是脑卒中的重要危险因素。我们评估了近几十年来高血压对缺血性中风风险的重要性是否有所增加。方法对西班牙塞维利亚3家医院1999-2001年、2014-2016年和2019-2020年出院的缺血性脑卒中患者进行回顾性研究。结果纳入1379名患者,女性42.6%,平均年龄69.1(±11)岁。HT是所有时期最常见的血管风险因素,高血压患者的血管风险逐渐增加(65.9%对69.6%对74%;P=0.029)。HT在≥80岁的患者中尤其常见(73%对81.9%对85.2%;P=0.029,降压药的使用量明显增加(平均0.9±0.8 vs 1.5±1 vs 1.8±0.8,P=0.001)。利尿剂(13.7%-39.3%-65.3%;P=0.001)、血管紧张素转换酶抑制剂(35.5%-43.3%-53.4%;P=0.0001)和血管紧张素受体阻滞剂(12.2%-24%-32.4%;P=.0001)的使用量逐渐增加。相反,钙拮抗剂的使用减少了(24%-19.9%-13.7%;P=0.0001)。结论在过去20年中,HT在首次缺血性脑血管事件患者中发挥了更大的作用。为了减轻脑血管疾病的巨大负担,有必要对HT进行更大更好的控制。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Importancia de la hipertensión en pacientes con primer episodio de ictus isquémico: estudio retrospectivo de 20 años

Background and objectives

Hypertension (HT) is a key risk factor for stroke. We evaluated whether the importance of hypertension on the risk of ischemic stroke has increased in recent decades.

Methods

Retrospective study of patients with ischemic stroke discharged from 3 hospitals in Seville (Spain), during the periods: 1999-2001, 2014-2016 and 2019-2020.

Results

1,379 patients were included, 42.6% women, mean age 69.1 (± 11) years. HT was the most prevalent vascular risk factor in all periods, with a progressive increase in hypertensive patients (65.9% vs 69.6% vs 74%; P = .029). HT was especially frequent in patients  80 years (73% vs 81.9% vs 85.2%; P = .029). At discharge, progressively more antihypertensive drugs were used (in 65% vs 85.1 vs 90.2% of patients; P = .0001), with a clear increase in the number of antihypertensive drugs used (mean 0.9 ± 0.8 vs 1.5 ± 1 vs 1.8 ± 0.8 drugs, P = .0001). The use of diuretics (13.7%-39.3%-65.3%; p = 0.0001), ACE inhibitors (35.5%-43.3%-53.4%; P = .0001) and angiotensin receptor blockers (12.2%-24%-32.4%; P = .0001) increased progressively. On the contrary, the use of calcium antagonists decreased (24%-19.9%-13.7%; P = .0001).

Conclusions

In the last 2 decades there has been a greater role for HT among patients with their first ischemic cerebrovascular event. Greater and better control of HT is necessary to reduce the enormous burden of cerebrovascular disease.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Hipertension y Riesgo Vascular
Hipertension y Riesgo Vascular Medicine-Internal Medicine
CiteScore
1.70
自引率
16.70%
发文量
38
审稿时长
39 days
期刊介绍: La mejor publicación para mantenerse al día en los avances de la lucha contra esta patología. Incluye artículos de Investigación, Originales, Revisiones, Casos clínicos, Aplicación práctica y Resúmenes comentados a la bibliografía internacional. Además, es la Publicación Oficial de la Sociedad española de Hipertensión-Liga Española para la Lucha contra la Hipertensión Arterial.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信